← Back to Search

Tissue Engineering

Nipple-Areola Complex Grafts for Breast Reconstruction After Cancer

N/A
Recruiting
Led By Geoffrey C Gurtner
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient age 18-65
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 months
Awards & highlights

Study Summary

This trial will study the safety and healing of nipple-areola complex reconstruction using BioAesthetics' decellularized human nipple-areolar complex graft.

Who is the study for?
This trial is for breast cancer patients aged 18-65 who've had autologous breast reconstruction and want nipple-areolar complex (NAC) grafting at least 3 months later. They must not smoke, have a stable weight, avoid certain substances before healing, and be free from severe health issues or treatments like chemo.Check my eligibility
What is being tested?
The study tests the safety and effectiveness of BioAesthetics' decellularized human NAC grafts in terms of healing time, satisfaction, well-being, self-esteem, body image, psychological state, and nipple sensitivity after surgery.See study design
What are the potential side effects?
While specific side effects are not listed here, potential risks may include infection at the surgery site, allergic reactions to the graft material if any sensitivities exist or complications related to wound healing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time to healing of implanted NACgraft

Trial Design

1Treatment groups
Experimental Treatment
Group I: NACgraft patientsExperimental Treatment1 Intervention
uni- or bilateral engraftment surgery will be performed

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,393 Previous Clinical Trials
17,341,301 Total Patients Enrolled
60 Trials studying Breast Cancer
111,165 Patients Enrolled for Breast Cancer
Geoffrey C GurtnerPrincipal InvestigatorStanford Universiy

Media Library

dcl-hNAC Graft (Tissue Engineering) Clinical Trial Eligibility Overview. Trial Name: NCT04534010 — N/A
Breast Cancer Research Study Groups: NACgraft patients
Breast Cancer Clinical Trial 2023: dcl-hNAC Graft Highlights & Side Effects. Trial Name: NCT04534010 — N/A
dcl-hNAC Graft (Tissue Engineering) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04534010 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

For whom is this medical experiment available?

"This clinical trial is enrolling 15 individuals with breast cancer, aged between 18 and 65. The following additional criteria must be met in order to participate: abstaining from aspirin, alcohol or excessive caffeine for 6 weeks; not undergoing NAC tattooing for 12 months; sleeping on back until grafts healed (6 weeks)."

Answered by AI

What is the current capacity for enrolment in this clinical trial?

"Affirmative. According to data provided by clinicaltrials.gov, this medical trial was initiated on April 28th 2021 and is currently recruiting participants for its study. At the moment, 15 patients are needed from 1 site."

Answered by AI

Is there capacity for additional participants in this trial?

"Indeed, the information posted on clinicaltrials.gov substantiates that this scientific research is currently in search of participants. Originally published on April 28th 2021, it was recently amended on May 3rd 2022 and requires 15 individuals to be recruited from a single location."

Answered by AI

Is eligibility for this study restricted to individuals under the age of sixty?

"According to the prerequisites for enrolment, only individuals between 18 and 65 years old are eligible. Those looking for studies related to younger people have 52 options while those seeking trials involving senior patients can pick from 1335 different ones."

Answered by AI
~2 spots leftby Dec 2024